StockNews.com initiated coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Free Report) in a report issued on Sunday morning. The firm issued a hold rating on the stock. Brooklyn ImmunoTherapeutics Price Performance BTX opened at $2.75 on Friday. Brooklyn ImmunoTherapeutics has a fifty-two week low of $0.17 and a fifty-two week high of $10.10. The […]